Maria Marvich

Array ( [id] => 4698874 [patent_doc_number] => 20080221058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'Tumor-Specific Vector for Gene Therapy' [patent_app_type] => utility [patent_app_number] => 12/030605 [patent_app_country] => US [patent_app_date] => 2008-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4557 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20080221058.pdf [firstpage_image] =>[orig_patent_app_number] => 12030605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6442386 [patent_doc_number] => 20100104641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'THERAPEUTIC COMPOSITION, AND USE OF A CELL-FREE SUBSTANCE' [patent_app_type] => utility [patent_app_number] => 12/525481 [patent_app_country] => US [patent_app_date] => 2008-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4884 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20100104641.pdf [firstpage_image] =>[orig_patent_app_number] => 12525481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5271581 [patent_doc_number] => 20090075357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'PRODUCTION OF RECOMBINANT AAV VIRIONS' [patent_app_type] => utility [patent_app_number] => 12/020395 [patent_app_country] => US [patent_app_date] => 2008-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10206 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075357.pdf [firstpage_image] =>[orig_patent_app_number] => 12020395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7687316 [patent_doc_number] => 20090176975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'METHODS AND COMPOSITIONS FOR DETECTING PROMOTER ACTIVITY AND EXPRESSING FUSION PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/019785 [patent_app_country] => US [patent_app_date] => 2008-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 164 [patent_figures_cnt] => 164 [patent_no_of_words] => 95482 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176975.pdf [firstpage_image] =>[orig_patent_app_number] => 12019785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5415853 [patent_doc_number] => 20090041740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'CANCER TREATMENT BY METABOLIC MODULATIONS' [patent_app_type] => utility [patent_app_number] => 12/017902 [patent_app_country] => US [patent_app_date] => 2008-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 25972 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20090041740.pdf [firstpage_image] =>[orig_patent_app_number] => 12017902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6134515 [patent_doc_number] => 20110008417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'IMMUNOMODULATING COMPOSITIONS AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 12/811304 [patent_app_country] => US [patent_app_date] => 2008-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 30940 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008417.pdf [firstpage_image] =>[orig_patent_app_number] => 12811304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8293954 [patent_doc_number] => 08221741 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-17 [patent_title] => 'Methods for modulating inflammatory and/or immune responses' [patent_app_type] => utility [patent_app_number] => 12/448903 [patent_app_country] => US [patent_app_date] => 2008-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 18150 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12448903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5501688 [patent_doc_number] => 20090162376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints' [patent_app_type] => utility [patent_app_number] => 12/005069 [patent_app_country] => US [patent_app_date] => 2007-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 70 [patent_figures_cnt] => 70 [patent_no_of_words] => 45378 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162376.pdf [firstpage_image] =>[orig_patent_app_number] => 12005069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8016825 [patent_doc_number] => 08137914 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-20 [patent_title] => 'Variants of alpha-fetoprotein coding and expression sequences' [patent_app_type] => utility [patent_app_number] => 11/963207 [patent_app_country] => US [patent_app_date] => 2007-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10923 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/137/08137914.pdf [firstpage_image] =>[orig_patent_app_number] => 11963207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6582460 [patent_doc_number] => 20100129914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'Tol1 FACTOR TRANSPOSASE AND DNA INTRODUCTION SYSTEM USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/518967 [patent_app_country] => US [patent_app_date] => 2007-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 31861 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20100129914.pdf [firstpage_image] =>[orig_patent_app_number] => 12518967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4903516 [patent_doc_number] => 20080112929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'SHIELDED ADENOVIRAL VECTORS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 11/947771 [patent_app_country] => US [patent_app_date] => 2007-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 25637 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20080112929.pdf [firstpage_image] =>[orig_patent_app_number] => 11947771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10870114 [patent_doc_number] => 08895309 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-25 [patent_title] => 'Myostatin inhibition for enhancing muscle and/or improving muscle function' [patent_app_type] => utility [patent_app_number] => 12/516995 [patent_app_country] => US [patent_app_date] => 2007-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 12849 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12516995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6487619 [patent_doc_number] => 20100285584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'ENGINEERED CELLULAR PATHWAYS FOR PROGRAMMED AUTOREGULATION OF DIFFERENTIATION' [patent_app_type] => utility [patent_app_number] => 12/312197 [patent_app_country] => US [patent_app_date] => 2007-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 154 [patent_figures_cnt] => 154 [patent_no_of_words] => 27895 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12312197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7550559 [patent_doc_number] => 08062891 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-22 [patent_title] => 'Nonviral vectors for delivering polynucleotides to plants' [patent_app_type] => utility [patent_app_number] => 11/930892 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17714 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/062/08062891.pdf [firstpage_image] =>[orig_patent_app_number] => 11930892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7811203 [patent_doc_number] => 08133733 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-13 [patent_title] => 'Nonviral vectors for delivering polynucleotides to target tissues' [patent_app_type] => utility [patent_app_number] => 11/932674 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13429 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/133/08133733.pdf [firstpage_image] =>[orig_patent_app_number] => 11932674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4903949 [patent_doc_number] => 20080113362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'METHODS FOR ISOLATING AND CHARACTERIZING ENDOGENOUS mRNA-PROTEIN (mRNP) COMPLEXES' [patent_app_type] => utility [patent_app_number] => 11/927781 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13996 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113362.pdf [firstpage_image] =>[orig_patent_app_number] => 11927781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5495762 [patent_doc_number] => 20090263790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'Methods for Identifying Functionally Related Genes and Drug Targets' [patent_app_type] => utility [patent_app_number] => 11/926286 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 20216 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20090263790.pdf [firstpage_image] =>[orig_patent_app_number] => 11926286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8294191 [patent_doc_number] => 08221971 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-17 [patent_title] => 'Serotype of adenovirus and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/980222 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 44 [patent_no_of_words] => 35699 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 217 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11980222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4663554 [patent_doc_number] => 20080254461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'METHODS FOR ISOLATING AND CHARACTERIZING ENDOGENOUS mRNA-PROTEIN (mRNP) COMPLEXES' [patent_app_type] => utility [patent_app_number] => 11/926091 [patent_app_country] => US [patent_app_date] => 2007-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13992 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20080254461.pdf [firstpage_image] =>[orig_patent_app_number] => 11926091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4839870 [patent_doc_number] => 20080280356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site' [patent_app_type] => utility [patent_app_number] => 11/977787 [patent_app_country] => US [patent_app_date] => 2007-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 22665 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20080280356.pdf [firstpage_image] =>[orig_patent_app_number] => 11977787 [rel_patent_id] =>[rel_patent_doc_number] =>)